Novo Nordisk

Dr Reddy’s consolidated net profit dropped 9.5% to  <span class='webrupee'>₹</span>1,342 crore in the second quarter of FY25. Image: Pixabay

Dr. Reddy’s to Expand GLP-1 Product Portfolio, Focus on Obesity and Diabetes Drug Markets

2024-11-05 20:42:29 : MUMBAI: Pharmaceutical major Dr. Reddy’s Laboratories Ltd aims to have around 15 GLP-1 drugs in its portfolio to treat obesity and ...